Navigation Links
Gemzar in Medical News

Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting

...088. Important Safety Information for gemzar (gemcitabine HCl for injection) gemzar is indicated in combination with cisplatin (anothe...ng cancer for whom surgery is not possible. gemzar may not be appropriate for some patients. I...

Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance

...act of foreign exchange rates, partially offset by higher prices. gemzar gemzar sales totaled $353.2 million in the second quarter of 2009, a decrease of 2...

Avastin Shows No Benefit Against Early Stage Colon Cancer

... turned up largely negative results. One trial found no difference in survival for pancreatic cancer patients who received the chemotherapy regimen gemzar (gemcitabine) or 5-FU/FA (fluorouracil/folinic acid) after surgery. Gemzar, however, did have fewer side effects, which is "extremely important," s...

Lilly Reports Strong First-Quarter 2009 Results

...pact of foreign exchange rates, partially offset by increased demand. gemzar gemzar sales totaled $367.8 million in the first quarter of 2009, a decrease of 14...

Lilly Reports Fourth-Quarter and Full-Year 2008 Results

... 414.2 11% 1,735.8 1,474.6 18% gemzar ( R ) 413.3 425.5 (3)% 1,719.8 ...avorable impact of foreign exchange rates. gemzar gemzar sales totaled $413.3 million in the fourth quarter...

New Hope for Tough-to-Treat Cancers

...oubled their overall survival when the cancer drug gemzar was used after surgery, new research shows. Unf...d Saturday at ASCO's annual meeting in Chicago. gemzar (gemcitabine) is the standard treatment for pancre...t three years, 23.5 percent of participants taking gemzar had survived without a recurrence, versus 7.5 perc...

Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer

...oking statements about the potential of ALIMTA and gemzar for the treatment of non-small cell lung cancer an...nsitivity to GEMZAR. Warnings Infusion times of gemzar longer than 60 minutes and more frequent than week...as been reported very rarely in patients receiving gemzar alone or in combination with other potentially hep...

Lilly Caps Successful Year with Strong Fourth-Quarter Results

...ed demand and favorable exchange rates. Gemzar gemzar sales totaled $425.5 million for the fourth quarte...sed demand. For the full year of 2007, worldwide gemzar sales increased 13 percent, to $1.592 billion. U.S. gemzar sales for 2007 were $670.0 million, a 10 percent i...

Lilly Delivers Strong Third-Quarter Results

.... Cymbalta continues to gain market share in the U.S. and internationally. gemzar gemzar had sales totaling $394.4 million for the third quarter, an increase of 11 ...

Gemzar the New Drug for Recurrent Ovarian Cancer

... The FDA has approved gemzar for the treatment of recurrent ovarian cancer igno...g the advice of the FDA panel.// It said that gemzar in combination with carboplatin (chemotherapy) is ... for women with advanced ovarian cancer. The drug gemzar also known by its generic name gemcitabine and was...
Gemzar in Medical Technology

Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

...30-35 Gy). Important Safety Information for gemzar (gemcitabine HCl for injection) gemzar is indicated in combination with cisplatin (anothe...lung cancer for whom surgery is not possible. gemzar is indicated in combination with carboplatin (anot...

Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference

...es at escalating doses ranging from 50mg to 110mg. gemzar was administered at the standard dose and schedule...ne week of rest. Results demonstrated MGCD0103 and gemzar can be safely administered together at the recomme...ly signs of clinical activity for the MGCD0103 and gemzar combination in solid tumor patients and particular...

Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer

...TA plus cisplatin demonstrated similar efficacy to gemzar plus cisplatin, a widely used regimen for first-li...pa.eu/humandocs/PDFs/EPAR/alimta/H-564-PI-en.pdf gemzar ABBREVIATED PRESCRIBING INFORMATION Uses gemzar is indicated for the treatment of adults with: No...

Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007

...nts with advanced head and neck squamous cell cancer -- GEMZAR(R) (gemcitabine HCl for injection) -- Phase III Study of gemzar Combination in Neoadjuvant (Pre-Surgical) Breast Cancer -- Abstract # 595: June 2, 2007; 2:00 p.m. -- Neoadjuvan...

Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment

...can patients with stage IIIB/IV NSCLC treated with gemzar in combination with carboplatin or paclitaxel (Tax... a logical starting point for our analysis." The gemzar study released at ASCO analyzed overall survival d... The trial was designed to compare the efficacy of gemzar plus carboplatin with GEMZAR plus paclitaxel and a...
Gemzar in Biological Technology

Lilly Set to Unveil More Than 50 Studies at ASCO 2009

... Studies of note for gemzar include: Abstract #CRA5507: Or...0-FDA-1088. Important Safety Information for gemzar (gemcitabine HCl for injection) gemzar is indicated in combination with cisplatin (anothe...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

...-5979. Important Safety Information for GEMZAR gemzar is indicated in combination with cisplatin (anothe... the dose-limiting toxicity with GEMZAR therapy. gemzar may not be appropriate for some patients. If you a...EMZAR, tell your doctor you should not receive it. gemzar can suppress bone marrow function. There have been...

Lilly Reports Solid Second-Quarter Results

...nge rates. Higher demand outside the U.S. reflects both increased demand in established markets, as well as recent launches in new markets. Gemzar gemzar sales totaled $440.1 million in the second quarter of 2008, an increase of 11 percent from the second quarter of 2007. Sales in the U.S. increased 11 ...

Lilly Reports Solid First-Quarter Results

...ere $94.0 million, an increase of 69 percent, driven primarily by higher demand, as well as the favorable impact of foreign exchange rates. Gemzar gemzar sales totaled $426.2 million in the first quarter on 2008, an increase of 13 percent from the first quarter of 2007. Sales in the U.S. increased 8 per...
Other Tags
(Date:3/28/2015)... New York (PRWEB) March 28, 2015 ... ) involving devices manufactured by C.R. Bard, Inc. ... underway in U.S. District Court, Southern District of ... Grand, is serving on the Plaintiffs’ Steering Committee. ... the Court has granted certain defendants named in ...
(Date:3/28/2015)... Centurion Service Group will be hosting a live on-site ... their Las Vegas warehouse, located at 4606 Andrews St. Suite ... of equipment from hospitals and surgery centers from around the ... , Buyers will find items of all types including anesthesia, ... said Erik Tivin, CEO of Centurion. , Among the sale’s ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 Early ... patients with Type V AC joint injuries, according to ... presented today at the American Orthopaedic Society for Sports ... returned to duty faster when surgery was not performed. ... with 7 receiving surgical treatment and 17 receiving non-surgical ...
(Date:3/28/2015)... March 28, 2015 Healthpointe’s otolaryngologists, medical ... and throat disorders, are now offering a wide ... issue which is characterized by the presence of phantom ... 5 people, tinnitus is a prevalent symptom that can ... it is non-fatal, tinnitus can impede a person’s quality ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Servpro ... , this week released a report about the link ... of asthma sufferers, and according to recent medical research, ... , According to the Environmental Protection Agency, people with ... reactions. Breathing in mold may trigger asthma attacks for ...
Breaking Medicine News(10 mins):Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3
(Date:3/11/2015)... 11, 2015 Research and Markets ( ... "Access Control Market by Product, Application & By Geography ... to their offering. , This report predicts ... $10.4 billion by 2020, with an estimated CAGR of ... the products types such as contact cards & readers, ...
(Date:3/10/2015)... March 10, 2015   Tute Genomics , pioneer ... selected by next-generation sequencing company PrimBio Research Institute ... and targeted gene panel interpretation. PrimBio, a ... the most current technologies to support the work of ... company offers two types of exome sequencing services: 1) ...
(Date:3/3/2015)... FOREST, Calif. , March 3, 2015 ... the leading provider of advanced cryogenic logistics ... markets including immunotherapies, stem cells, cell lines, ... and reproductive medicine, today announced the expansion ... Cancer Research Centers, ("Fred Hutch") Clinical ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
Other Contents